Given that the PI3K-AKT signaling is constitutively activated in MCL [29,30], we thus reasoned that PI3K-AKT signaling is responsible for the alteration of the cell cycle by inactivating FOXO1 in the FARSA-manipulated MCL cells. The gene discussed is PIK3CB; the disease is mantle cell lymphoma.